Applications of Rule‐Based Methods to Data Mining of Polypharmacology Data Sets

[1]  Lucille J. Brown.  The Markush challenge , 1991, J. Chem. Inf. Comput. Sci..

[2]  Daniel J. Warner,et al.  Matched molecular pairs as a medicinal chemistry tool. , 2011, Journal of medicinal chemistry.

[3]  Eugen Lounkine,et al.  Molecular Formal Concept Analysis for Compound Selectivity Profiling in Biologically Annotated Databases , 2009, J. Chem. Inf. Model..

[4]  Dragos Horvath,et al.  Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.

[5]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[6]  J F McElroy,et al.  Novel piperidine sigma receptor ligands as potential antipsychotic drugs. , 1992, Journal of medicinal chemistry.

[7]  R. Morphy.  Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.

[8]  Ian A. Watson,et al.  Rationalizing Lead Optimization by Associating Quantitative Relevance with Molecular Structure Modification , 2009, J. Chem. Inf. Model..

[9]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[10]  Jürgen Bajorath,et al.  Distinguishing between Bioactive and Modeled Compound Conformations through Mining of Emerging Chemical Patterns , 2008, J. Chem. Inf. Model..

[11]  Heather S. Gruver,et al.  Data analysis of high-throughput screening results: application of multidomain clustering to the NCI anti-HIV data set. , 2002, Journal of medicinal chemistry.

[12]  Robert D. Clark,et al.  Structural Unit Analysis Identifies Lead Series and Facilitates Scaffold Hopping in Combinatorial Chemistry , 2006, J. Chem. Inf. Model..

[13]  Eugen Lounkine,et al.  Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds. , 2008, Journal of medicinal chemistry.

[14]  Bin Chen,et al.  Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..

[15]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir , 2011, PLoS Comput. Biol..

[16]  Luc De Raedt,et al.  SMIREP: Predicting Chemical Activity from SMILES , 2006, J. Chem. Inf. Model..

[17]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[18]  Marie-Dominique Devignes,et al.  Comparison of Three Preprocessing Filters Efficiency in Virtual Screening: Identification of New Putative LXRβ Regulators As a Test Case , 2010, J. Chem. Inf. Model..

[19]  Mohammad Afshar and Nathalie Jullian.  Novel Rule-Based Method for Multi-Parametric Multi-Objective Decision Support in Lead Optimization Using KEM , 2008 .

[20]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[21]  Gavin Harper,et al.  Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. , 2008, Journal of medicinal chemistry.

[22]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[23]  Stephen Muggleton,et al.  Scaffold Hopping in Drug Discovery Using Inductive Logic Programming , 2008, J. Chem. Inf. Model..

[24]  Michael M. Hann,et al.  RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..

[25]  Cavero,et al.  QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. , 1999, Pharmaceutical science & technology today.

[26]  Alexandre Varnek,et al.  Building a chemical space based on fragment descriptors. , 2008, Combinatorial chemistry & high throughput screening.

[27]  Ravi Iyengar,et al.  Network analyses in systems pharmacology , 2009, Bioinform..

[28]  Anne Mai Wassermann,et al.  Directed R-group combination graph: a methodology to uncover structure-activity relationship patterns in a series of analogues. , 2012, Journal of medicinal chemistry.

[29]  D. Mukhopadhyay,et al.  Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics. , 2011, Journal of medicinal chemistry.

[30]  Lisa Jarvis.  TEACHING AN OLD DRUG NEW TRICKS , 2006 .

[31]  Jürgen Bajorath,et al.  Molecular Scaffolds with High Propensity to Form Multi-Target Activity Cliffs , 2010, J. Chem. Inf. Model..

[32]  G Klopman,et al.  Diversity analysis of 14 156 molecules tested by the National Cancer Institute for anti-HIV activity using the quantitative structure-activity relational expert system MCASE. , 1999, Journal of medicinal chemistry.

[33]  K. Shokat,et al.  Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.

[34]  Tomasz Imielinski,et al.  Mining association rules between sets of items in large databases , 1993, SIGMOD Conference.

[35]  Bin Chen,et al.  PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..